Connecting Our
Rare Communities to
Clinical Trial Opportunities
Direct Exposure to Rare Disease Community
Education and Raising Awareness
Patient-powered Social Media Campaign Development
Patient Recruitment
Patient Journey
Coming Soon
Protocol Design
Coming Soon
Community Access
Coming Soon
The BioNews Impact
We know clinical recruitment is challenging.
We can help.
Challenge
Opportunity
Clinical trials need a significant number of participants in order to be completed.
We have brought together over 2M people living with rare diseases.
Finding a sufficient number of patients living with a rare disease is not simple.
Most of them, when asked, are interested in knowing more about ongoing clinical trials.
Fewer than 5% of patients participate in clinical trials. For patients living with rare diseases, participation is lower than 1%.
80% of clinical trials are delayed due to slow patient enrollment
We accelerate your clinical trial recruitment by tapping into our engaged community of patients who voiced their desire in learning more and participating in a clinical trial.
Patient involvement in clinical trials has been shown to generate a 500-fold return in investment and to speed new drugs to market by 2.5 years; however, meaningful engagement with patients is not the norm.
We offer you a defined and regulated process to engage with patients in all phases of your clinical trial process.
The average cost to recruit just one patient volunteer in a clinical trial is more than $40,000.
Our business model is designed to align with your goals.
The BioNews Impact
We know clinical recruitment is challenging.
We can help.
Challenge
Clinical trials need a significant number of participants in order to be completed.
Opportunity
We have brought together over 2 M people living with rare diseases.
Challenge
Finding a sufficient number of patients living with a rare disease is not simple.
Opportunity
Most of them, when asked, are interested in knowing more about ongoing clinical trials.
Challenge
Less than 5% of patients participate in clinical trials. For patients living with rare diseases, participation is lower than 1%.
80% of clinical trials are delayed due to slow patient enrollment
Opportunity
We accelerate your clinical trial recruitment by tapping into our engaged community of patients who voiced their desire in learning more and participating in a clinical trial.
Challenge
Patient involvement in clinical trials has been shown to generate 500-fold return in investment and to speed new drugs to market by 2.5 years, however meaningful engagement with patients is not the norm
Opportunity
We offer you a defined and regulated process to engage with patients in all phases of your clinical trial process
Challenge
The average cost to recruit just one patient volunteer in a clinical trial is over $40,000
Opportunity
Our business model is designed to align with your goals
The Numbers
2+ million
Number of users per month across our platforms
79%
Average percentage of patient population reached per month
More than 125,000
Hours spent on BioNews sites each month
Latest News
Trial of Xadago in Treating Levodopa-induced Dyskinesia Planned
Newron Pharmaceuticals and Zambon Pharma agreed to jointly support a potentially pivotal clinical trial of Xadago (safinamide) as a treatment of levodopa-induced dyskinesia in people...
Bacteria in Patients’ Guts Show Changes That May Weigh on Disease
People with Parkinson’s disease have substantial changes in the bacteria living in their gut relative to people without this neurodegenerative disorder, an analysis underscores. “This dysbiosis...
Surveys Play a Critical Role in Improving the Patient Experience
I used to dislike surveys, polls, and questionnaires. I understood why they existed — customer or patient feedback is important — but I never really saw anything change once I took a survey. I...